Pharma

Former Apple CEO John Sculley speaks with Wainwright Fishburn, of Cooley LLP during the BIO18 event on Wednesday.

Former Apple CEO John Sculley speaks with Wainwright Fishburn, of Cooley LLP during the BIO18 event on Wednesday.

By Dave Muoio June 6, 2018
When it comes to the challenges of raising an up-and-coming young company into a major player in its industry, former Apple and Pepsi CEO John Sculley is no spring chicken. A serial entrepreneur and investor across numerous industries ranging from consumer technology to data management to telecommunications, Sculley has set his sights on the healthcare and currently serves as the chairman of...
By Laura Lovett May 24, 2018
This week Blink Health, which makes an app and online tool for helping consumers find low prices for medications, filed a new legal claim against former partner MedImpact Healthcare System alleging greed and misconduct while describing the company as a “peddler of opioids.”  This claim comes as a second amendment to another ongoing lawsuit between the two companies, which seeks a trial by jury...
By Jonah Comstock May 22, 2018
Specialty pharmaceuticals are all different, but there’s one thing they have in common: they are difficult to prescribe. Whether it’s because of high cost, high risk, narrow therapeutic range, or complicated dosing, these drugs require would-be prescribing physicians to prove to insurers the drug is the right choice for their patient by filling out a number of forms and providing key data about...
By Jonah Comstock May 17, 2018
Sanofi’s approach to digital health is broad, but focused, Rachel Sha, the company’s vice president of digital business development and licensing, told Babyforyou.net.ua in an interview ahead of the upcoming BIO 2018 conference in Boston, where Sha will be speaking on a range of digital health-related topics. “At Sanofi we’re lucky in the sense that we have a very clear set of digital priorities...
By Jonah Comstock May 16, 2018
Cambridge, Massachusetts-based sensor maker MC10, known for its flexible and stretchable electronics, has received its first FDA 510(k) clearance for the BioStamp nPoint system. BioStamp nPoint is a more advanced version of the company's non-FDA cleared BioStampRC. "BiostampRC was primarily developed as an investigational tool, primarily used by academia, as well as by pharmaceutical companies,...
By Laura Lovett May 16, 2018
DNA, health records, and blood test results are not only intimately personal, they are also a valuable asset to researchers. Recently a smattering of companies have been working to create a market for people to share and sell their personal data to researchers and healthcare players. Those efforts are going one step further, as two growing names in the health data and blockchain industry are...
By Dave Muoio May 14, 2018
Verily researchers have built prototype devices for painless blood collection that uses a system of “exploding” micro-needles, magnets, and potentially a blood storage chamber, CNBC reports. Information on the device was received from several anonymous sources, who CNBC said did not want to be named as the project is still unannounced. “Several sources aware of the company's plans say the device...
By Dave Muoio May 3, 2018
Garmin and the University of Kansas Medical Center are taking a closer look at the role wearables can play in detecting and managing medical conditions, the groups announced earlier this week. Initially focused on sleep apnea and atrial fibrillation, the collaboration is a clear step beyond the fitness and wellness realm to which Garmin’s wearables have so far been limited. “Garmin Health is...
By Dave Muoio May 2, 2018
In a recent medium.com blog post, Daphne Koller — an artificial intelligence researcher at the Department of Computer Science at Stanford University and, until just a few months ago, chief computing officer at Alphabet’s Calico Labs — announced her up-and-coming foray into machine learning-powered drug discovery. Called insitro (a portmanteau of “in silico” and “in vitro”), the new endeavor looks...
By Laura Lovett April 25, 2018
Like almost any field in the healthcare industry pharma wants to get in on the latest technology trends. Recently big pharma has been looking to artificial intelligence as another tool to help facilitate drug research and help the company progress.  At the World Medical Innovation Forum in Boston on April 24, a panel of pharma leaders discussed the future of AI in the industry.  “It's quite top...

Editor's Pick